BioSpace News Archive

Since the China launch earlier this year of an immuno-oncology drug at one-third the price of Merck’s Keytruda, there has been a wave of applications for affordable innovative therapies from China, developed to Western standards of safety and efficacy, to register in the US.

OncLive®, the nation’s leading multimedia resource focused on providing oncology professionals with the most current and insightful information they need to provide the best patient care, will host its latest State of the Science Summit™ on breast cancer Thursday, June 27, from 5-9:30 p.m. at the Millennium Hilton New York One UN Plaza.

Physicians Endoscopy, LLC in partnership with University Hospitals Cleveland received successful licensure on May 2, 2019, in the newly developed GI ambulatory surgery center in North Ridgeville, Ohio.

Locust Walk, a global life science transaction firm, today announced the appointments of Neil Higgins, Managing Director of Financing, and Turner Grant, Senior Vice President of Financing

Grifols (MCE: GRF, MCE: GRF.P, NASDAQ: GRFS), one of the world’s three top providers of plasma-derived medicines to treat life-threatening diseases, today announced that the VISTASEAL™ fibrin sealant will be the first product it will introduce with Ethicon Inc. as part of a broad global relationship to provide plasma-protein-based solutions to manage surgical bleeding.

Arizona’s only “Best Children’s Hospital” is one of just 10 programs nationwide to earn three-star designation

Bayer announced today that the Stivarga® (regorafenib) arm of the platform trial GBM AGILE (Glioblastoma Adaptive Global Innovative Learning Environment) has opened enrollment for patients with newly diagnosed and recurrent glioblastoma, the most aggressive and common form of primary brain cancer

Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott released the following statement on the Senate Special Committee on Aging’s hearing, “The Complex Web of Prescription Drug Prices, Part III: Examining Agency Efforts to Further Competition and Increase Affordability:"

A cost-effectiveness analysis completed by the University of California, San Francisco (UCSF) and Baylis Medical has shown that use of Baylis’ RF transseptal needle results in cost savings per procedure, compared to use of a mechanical transseptal needle.

Health systems continue to invest significant time and resources in designing, negotiating and implementing various types of partnerships and affiliations.